Effect of narrow band UVB in combination with 0.1% topical Tacrolimus versus narrow band UVB alone on treatment of patients with vitiligo
Phase 2
- Conditions
- Vitiligo.Vitiligo
- Registration Number
- IRCT201606239014N103
- Lead Sponsor
- Vice-chancellor for Research the Technology, Hamadan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
presence of bilateral symmetrical vitiligo lesions on upper and lower limbs, face or trunk; fixed or progressive disease process; involvement of at least 10 percent body surface.
Exclusion criteria: using topical treatments in the past one month; immunodeficiency; any contraindication of phototherapy.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Measuring vitiligo score. Timepoint: before intervention and 1.5 and 3 months after intervention. Method of measurement: using VASI scoring scale.
- Secondary Outcome Measures
Name Time Method Assessing local adverse events (erythema and inflammation). Timepoint: 1.5 and 3 months after intervention. Method of measurement: through physical examination.